|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q and
Ajani JA: Gastric cancer-molecular and clinical dimensions. Nat Rev
Clin Oncol. 10:643–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pidgeon GP, Lysaght J, Krishnamoorthy S,
Reynolds JV, O'Byrne K, Nie D and Honn KV: Lipoxygenase metabolism:
Roles in tumor progression and survival. Cancer Metastasis Rev.
26:503–524. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gondek T, Szajewski M, Szefel J,
Aleksandrowicz-Wrona E, Skrzypczak-Jankun E, Jankun J and
Lysiak-Szydlowska W: Evaluation of 12-lipoxygenase (12-LOX) and
plasminogen activator inhibitor 1 (PAI-1) as prognostic markers in
prostate cancer. Biomed Res Int. 2014:1024782014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh AK, Kant S, Parshad R, Banerjee N
and Dey S: Evaluation of human LOX-12 as a serum marker for breast
cancer. Biochem Biophys Res Commun. 414:304–308. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Klampfl T, Bogner E, Bednar W, Mager L,
Massudom D, Kalny I, Heinzle C, Berger W, Stättner S, Karner J, et
al: Up-regulation of 12(S)-lipoxygenase induces a migratory
phenotype in colorectal cancer cells. Exp Cell Res. 318:768–778.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang KH, Ling TY, Liou HH, Huang YK, Hour
MJ, Liou HC and Fu WM: Enhancement role of host 12/15-lipoxygenase
in melanoma progression. Eur J Cancer. 49:2747–2759. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Buehler D, Hardin H, Shan W,
Montemayor-Garcia C, Rush PS, Asioli S, Chen H and Lloyd RV:
Expression of epithelial-mesenchymal transition regulators SNAI2
and TWIST1 in thyroid carcinomas. Mod Pathol. 26:54–61. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu
F, Ethier SP, Miller F and Wu G: Forkhead transcription factor
foxq1 promotes epithelial-mesenchymal transition and breast cancer
metastasis. Cancer Res. 71:1292–1301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu X, Zhai Y, Kong P, Cui H, Yan T, Yang
J, Qian Y, Ma Y, Wang F, Li H, et al: FAT1 prevents epithelial
mesenchymal transition (EMT) via MAPK/ERK signaling pathway in
esophageal squamous cell cancer. Cancer Lett. 397:83–93. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kamikihara T, Ishigami S, Arigami T,
Matsumoto M, Okumura H, Uchikado Y, Kita Y, Kurahara H, Kijima Y,
Ueno S and Natsugoe S: Clinical implications of N-cadherin
expression in gastric cancer. Pathol Int. 62:161–166. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Natalwala A, Spychal R and Tselepis C:
Epithelial-mesenchymal transition mediated tumourigenesis in the
gastrointestinal tract. World J Gastroenterol. 14:3792–3797. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kokkinos MI, Wafai R, Wong MK, Newgreen
DF, Thompson EW and Waltham M: Vimentin and epithelial-mesenchymal
transition in human breast cancer-observations in vitro and in
vivo. Cells Tissues Organs. 185:191–203. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tomita K, van Bokhoven A, van Leenders GJ,
Ruijter ET, Jansen CF, Bussemakers MJ and Schalken JA: Cadherin
switching in human prostate cancer progression. Cancer Res.
60:3650–3654. 2000.PubMed/NCBI
|
|
16
|
Mahmood MQ, Ward C, Muller HK, Sohal SS
and Walters EH: Epithelial mesenchymal transition (EMT) and
non-small cell lung cancer (NSCLC): A mutual association with
airway disease. Med Oncol. 34:452017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Geng XL, Long WH, Hai J, Zhang Y, Zheng W,
Zhang ZY and Du LX: The role of hexokinase 2 in the metastasis of
hepatocellular carcinoma cells. Zhonghua Zhong Liu Za Zhi.
38:739–742. 2016.(In Chinese). PubMed/NCBI
|
|
18
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao M, Li W, Wang H and Wang G: The
distinct expression patterns of claudin-10, −14, −17 and E-cadherin
between adjacent non-neoplastic tissues and gastric cancer tissues.
Diagn Pathol. 8:2052013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Czyzewska J, Guzińska-Ustymowicz K,
Ustymowicz M, Pryczynicz A and Kemona A: The expression of
E-cadherin-catenin complex in patients with advanced gastric
cancer: Role in formation of metastasis. Folia Histochem Cytobiol.
48:37–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan HB, Wang XF, Zhang Q, Tang ZQ, Jiang
YH, Fan HZ, Sun YH, Yang PY and Liu F: Reduced expression of the
chromatin remodeling gene ARID1A enhances gastric cancer cell
migration and invasion via downregulation of E-cadherin
transcription. Carcinogenesis. 35:867–876. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Chen CQ, He YL, Cai SR, Yang DJ, He
WL, Xu JB and Zan WH: Abnormal expression of E-cadherin in tumor
cells is associated with poor prognosis of gastric carcinoma. J
Surg Oncol. 106:304–310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang X, Qian Y, Wu H, Xie X, Zhou Q, Wang
Y, Kuang W, Shen L, Li K, Su J, et al: Aberrant expression of
osteopontin and E-cadherin indicates radiation resistance and poor
prognosis for patients with cervical carcinoma. J Histochem
Cytochem. 63:88–98. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yun JA, Kim SH, Hong HK, Yun SH, Kim HC,
Chun HK, Cho YB and Lee WY: Loss of E-Cadherin expression is
associated with a poor prognosis in stage III colorectal cancer.
Oncology. 86:318–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Techasen A, Loilome W, Namwat N, Khuntikeo
N, Puapairoj A, Jearanaikoon P, Saya H and Yongvanit P: Loss of
E-cadherin promotes migration and invasion of cholangiocarcinoma
cells and serves as a potential marker of metastasis. Tumour Biol.
35:8645–8652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen F, Zhuang M, Zhong C, Peng J, Wang X,
Li J, Chen Z and Huang Y: Baicalein reverses hypoxia-induced 5-FU
resistance in gastric cancer AGS cells through suppression of
glycolysis and the PTEN/Akt/HIF-1α signaling patway. Oncol Rep.
33:457–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rong S, Cao Q, Liu M, Seo J, Jia L,
Boudyguina E, Gebre AK, Colvin PL, Smith TL, Murphy RC, et al:
Macrophage 12/15 lipoxygenase expression increases plasma and
hepatic lipid levels and exacerbates atherosclerosis. J Lipid Res.
53:686–695. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nagasawa K, Kakuda T, Higashi Y and
Fujimoto S: Possible involvement of 12-lipoxygenase activation in
glucose-deprivation/reload-treated neurons. Neurosci Lett.
429:120–125. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dilly AK, Ekambaram P, Guo Y, Cai Y,
Tucker SC, Fridman R, Kandouz M and Honn KV: Platelet-type
12-lipoxygenase induces MMP9 expression and cellular invasion via
activation of PI3K/Akt/NF-κB. Int J Cancer. 133:1784–1791. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoshimura R, Inoue K, Kawahito Y,
Mitsuhashi M, Tsuchida K, Matsuyama M, Sano H and Nakatani T:
Expression of 12-lipoxygenase in human renal cell carcinoma and
growth prevention by its inhibitor. Int J Mol Med. 13:41–46.
2004.PubMed/NCBI
|
|
32
|
Yoshimura R, Matsuyama M, Mitsuhashi M,
Takemoto Y, Tsuchida K, Kawahito Y, Sano H and Nakatani T:
Relationship between lipoxygenase and human testicular cancer. Int
J Mol Med. 13:389–393. 2004.PubMed/NCBI
|
|
33
|
Wong BC, Wang WP, Cho CH, Fan XM, Lin MC,
Kung HF and Lam SK: 12-Lipoxygenase inhibition induced apoptosis in
human gastric cancer cells. Carcinogenesis. 22:1349–1354. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen FL, Wang XZ, Li JY, Yu JP, Huang CY
and Chen ZX: 12-lipoxygenase induces apoptosis of human gastric
cancer AGS cells via the ERK1/2 signal pathway. Dig Dis Sci.
53:181–187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nie D, Nemeth J, Qiao Y, Zacharek A, Li L,
Hanna K, Tang K, Hillman GG, Cher ML, Grignon DJ and Honn KV:
Increased metastatic potential in human prostate carcinoma cells by
overexpression of arachidonate 12-lipoxygenase. Clin Exp
Metastasis. 20:657–663. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao X and Honn KV: Biological properties
of 12(S)-HETE in cancer metastasis. Adv Prostaglandin Thromboxane
Leukot Res. 23:439–444. 1995.PubMed/NCBI
|
|
37
|
Honn KV, Tang DG, Gao X, Butovich IA, Liu
B, Timar J and Hagmann W: 12-lipoxygenases and 12(S)-HETE: Role in
cancer metastasis. Cancer Metastasis Rev. 13:365–396. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Torabizadeh Z, Nosrati A, Sajadi Saravi
SN, Yazdani Charati J and Janbabai G: Evaluation of E-cadherin
expression in gastric cancer and its correlation with
clinicopathologic parameters. Int J Hematol Oncol Stem Cell Res.
11:158–164. 2017.PubMed/NCBI
|
|
39
|
Anbiaee R, Mojir Sheibani K, Torbati P and
Jaam H: Abnormal expression of e-cadherin in gastric
adenocarcinoma, and its correlation with tumor histopathology and
helicobacter pylori infection. Iran Red Crescent Med J. 15:218–222.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lazăr D, Tăban S, Ardeleanu C, Dema A,
Sporea I, Cornianu M, Lazăr E and Vernic C: The immunohistochemical
expression of E-cadherin in gastric cancer; correlations with
clinicopathological factors and patients' survival. Rom J Morphol
Embryol. 49:459–467. 2008.PubMed/NCBI
|
|
41
|
Stemmler MP: Cadherins in development and
cancer. Mol Biosyst. 4:835–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma Y, Zheng X, Zhou J, Zhang Y and Chen K:
ZEB1 promotes the progression and metastasis of cervical squamous
cell carcinoma via the promotion of epithelial-mesenchymal
transition. Int J Clin Exp Pathol. 8:11258–11267. 2015.PubMed/NCBI
|
|
43
|
Zhao J, Yang C, Guo S and Wu Y: GM130
regulates epithelial-to-mesenchymal transition and invasion of
gastric cancer cells via snail. Int J Clin Exp Pathol.
8:10784–10791. 2015.PubMed/NCBI
|
|
44
|
Wang F, Li XK, Xu HY, Shan ZZ, Wang T,
Yang ZC, He W, Wang LX and Fan QX: N-cadherin participated in
invasion and metastasis of human esophageal squamous cell carcinoma
via taking part in the formation of vasculogenic mimicry. Med
Oncol. 32:4802015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yi S, Yang ZL, Miao X, Zou Q, Li J, Liang
L, Zeng G and Chen S: N-cadherin and P-cadherin are biomarkers for
invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Pathol Res Pract. 210:363–368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ye J, Huang J, Xu J, Huang Q, Wang J,
Zhong W and Lin X, Li Y and Lin X: ERp29 controls invasion and
metastasis of gastric carcinoma by inhibition of
epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
BMC Cancer. 17:6262017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Han M and Xu W: EMP3 is induced by
TWIST1/2 and regulates epithelial-to-mesenchymal transition of
gastric cancer cells. Tumour Biol. 39:10104283177184042017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Song Y, Li ZX, Liu X, Wang R, Li LW and
Zhang Q: The Wnt/β-catenin and PI3K/Akt signaling pathways promote
EMT in gastric cancer by epigenetic regulation via H3 lysine 27
acetylation. Tumour Biol. 39:10104283177126172017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen G, Tang N, Wang C, Xiao L, Yu M, Zhao
L, Cai H, Han L, Xie C and Zhang Y: TNF-α-inducing protein of
Helicobacter pylori induces epithelial-mesenchymal transition (EMT)
in gastric cancer cells through activation of IL-6/STAT3 signaling
pathway. Biochem Biophys Res Commun. 484:311–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Timmerman LA, Grego-Bessa J, Raya A,
Bertrán E, Pérez-Pomares JM, Díez J, Aranda S, Palomo S, McCormick
F, Izpisúa-Belmonte JC and de la Pompa JL: Notch promotes
epithelial-mesenchymal transition during cardiac development and
oncogenic transformation. Genes Dev. 18:99–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Huber MA, Azoitei N, Baumann B, Grünert S,
Sommer A, Pehamberger H, Kraut N, Beug H and Wirth T: NF-kappaB is
essential for epithelial-mesenchymal transition and metastasis in a
model of breast cancer progression. J Clin Invest. 114:569–581.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tashiro E, Henmi S, Odake H, Ino S and
Imoto M: Involvement of the MEK/ERK pathway in EGF-induced
E-cadherin down-regulation. Biochem Biophys Res Commun.
477:801–806. 2016. View Article : Google Scholar : PubMed/NCBI
|
